Objective: Glucose transporter 2 (GLUT2) is expressed in the pancreatic β-cell, intestine, liver, and kidney in mice. Although GLUT2 is considered as a major regulator of insulin secretion, in vivo contribution of β-cell to glucose-stimulated insulin secretion and systemic glucose homeostasis is undefined. Therefore, the main objective of this study is to determine the role of β-cell in regulating insulin secretion and blood glucose levels in mice.
Methods: We produced mice in which we can knock down at a desired time specifically in β-cells (β- KD) by crossing mice with mouse strain and using the Cre-Lox recombination technique. We measured fasting blood glucose levels, glucose tolerance, and glucose-stimulated insulin secretion in the β- KD mice. We used qRT-PCR and immunofluorescence to validate the deficiency of β-cell in β- KD mice.
Results: We report that both male and female β- KD mice have normal glucose-stimulated insulin secretion. Moreover, the β- KD mice exhibit normal fasting blood glucose levels and glucose tolerance. The β- KD mice have upregulated GLUT1 in islets.
Conclusions: Our findings demonstrate that normal β-cell expression is not essential for regulating glucose-stimulated insulin secretion and systemic glucose homeostasis in mice. Therefore, the currently assumed role of β-cell GLUT2 in regulating insulin secretion and blood glucose levels needs to be recalibrated. This will allow an opportunity to determine the contribution of other β-cell glucose transporters or factors whose normal expression may be necessary for mediating glucose stimulated insulin secretion.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10046365 | PMC |
http://dx.doi.org/10.3390/biom13030540 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!